15445
|
|
15448
|
|
15648
|
|
15649
|
|
15650
|
|
15667
|
Dupilumab Treatment Shows Rapid and Consistent Improvement in Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 17 Years: Results From an Open-Label Extension Study
Poster
1.1 Inflammatory and immune-mediated dermatoses
E. Siegfried Saint Louis University, St. Louis, MO, USA and Cardinal Glennon Children’s Hospital, St. Louis, MO, USAS. Straub
Conférencier
Sanofi-aventis (Swiss) SA, Switzerland. *Sebastian Straub has been added to serve as a presenter. Sanofi medical employees (Sebastian Straub and Michael Perny) will attend the congress and can address HCPs/researchers questions.E. Simpson Oregon Health & Science University, Portland, OR, USAM. Cork Sheffield Dermatology Research, University of Sheffield, Sheffield, UK, and Sheffield’s Children’s Hospital, Sheffield, UKH. Saeki Nippon Medical School, Tokyo, JapanZ. Chen Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAE. Simcox Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAR. Prescilla Sanofi, Cambridge, MA, USA
|
15720
|
|
15851
|
|
15852
|
AhR agonism by tapinarof regulates TH2 cell function in human skin
Poster
3.4 Basic and Translational Research
F. Luther
Conférencier
Inselspital, University Hospital Bern, Bern UniversityN. Bertschi Inselspital, University Hospital Bern, Bern UniversityS. Schärli Inselspital, University Hospital Bern, Bern UniversityL. Taylor Universität BernS. Radonjic-Hoesli Inselspital, University Hospital Bern, Bern UniversityN. Yawalkar Inselspital, University Hospital Bern, Bern UniversityD. Simon Inselspital, University Hospital Bern, Bern UniversityL. Borradori Inselspital, University Hospital Bern, Bern UniversityC. Schlapbach Inselspital, University Hospital Bern, Bern University
|
15853
|
IL-18 activates human Th2 cells in atopic dermatitis
Poster
3.4 Basic and Translational Research
S. Schärli
Conférencier
Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandF. Luther Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandT. Werfel Hannover Medical School (MHH), Hannover, GermanyJ. Thyssen Gentofte Hospital, Hellerup, DenmarkS. Eyerich Technical University and Helmholtz Center Munich, Munich, GermanyM. Gilliet CHUV University Hospital, University of Lausanne, Lausanne, SwitzerlandL. Borradori Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandN. Bertschi Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandC. Schlapbach Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
|
15854
|
IL-9 induces a type-1 interferon signature in pathogenic skin-tropic TH2 cells
Poster
3.4 Basic and Translational Research
N. Bertschi
Conférencier
Inselspital, University Hospital Bern, Bern UniversityA. Vallone Inselspital, University Hospital Bern, Bern UniversityF. Luther Inselspital, University Hospital Bern, Bern UniversityS. Schärli Inselspital, University Hospital Bern, Bern UniversityC. Bazzini Inselspital, University Hospital Bern, Bern UniversityI. Keller Universität BernL. Borradori Inselspital, University Hospital Bern, Bern UniversityD. Simon Inselspital, University Hospital Bern, Bern UniversityC. Schlapbach Inselspital, University Hospital Bern, Bern University
|
15862
|
|
15863
|
|
15864
|
Comorbid mental disorders in psoriasis patients and the effect of systemic psoriasis therapy: a real-world multicenter registry cohort study of the Swiss psoriasis registry (SDNTT)
Poster
1.1 Inflammatory and immune-mediated dermatoses
V. Schön
Conférencier
Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandL. Maul Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandN. Yawalkar Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandC. Conrad Department of Dermatology and Venereology, University Hospital of Lausanne, Lausanne, SwitzerlandA. Cozzio Department of Dermatology, Venereology and Allergology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandF. Anzengruber Cantonal Hospital of GraubündenW. Boehncke Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, SwitzerlandM. Streit Department of Dermatology, Cantonal Hospital Aarau, Aarau, SwitzerlandS. Sand Department of Dermatology, University Hospital Zurich, Zurich, SwitzerlandT. Kündig Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandA. Navarini Department of Dermatology, University Hospital Basel, Basel, SwitzerlandJ. Maul Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
|
15865
|
|
15866
|
|
15868
|
Propofol-induced generalized fixed drug eruption: A rare presentation of delayed type IV hypersensitivity
Poster
3.2 Dermato-Allergology
E. Gössinger
Conférencier
University Hospital Basel; University of BaselC. Guillet University Hospital Basel; University of BaselV. Hongler University Hospital Basel; University of BaselH. Juratli University Hospital Basel; University of BaselM. Madanchi University Hospital Basel; University of BaselK. Hartmann University Hospital Basel; University of BaselE. Steveling-Klein University Hospital Basel; University of BaselM. Beigi University Hospital Basel; University of Basel
|
15869
|
|
15870
|
Direct illumination multispectral imaging: A novel method for classifying melanocytic lesions
Poster
2.1 Dermato-Oncology
E. Gössinger
Conférencier
University Hospital BaselP. Dittrich Fraunhofer Institute for Applied Optics and Precision Engineering IOFG. Notni Technische Universität IlmenauP. Noecker Fraunhofer Institute for Applied Optics and Precision Engineering IOFS. Cerminara University Hospital BaselB. Mühleisen University Hospital BaselS. Weber FotoFinder System GmbHA. Navarini University Hospital BaselL. Maul University Hospital Basel
|
15872
|
|
15873
|
Unmasking “congenital” hemangiomas as infantile hemangiomas
Poster
3.1 Dermato-Paediatrics
N. Zhovta
Conférencier
Universitäts-Kinderspital ZürichL. Weibel Universitäts-Kinderspital ZürichM. Theiler Universitäts-Kinderspital ZürichA. Schwieger-Briel Universitäts-Kinderspital ZürichJ. Kamarachev Universitätsspital ZürichI. Luchsinger Universitäts-Kinderspital Zürich
|
15875
|
Exploring Serum Protein Profiles in Psoriasis Patients of Different Age Groups
Poster
1.1 Inflammatory and immune-mediated dermatoses
I. Birkenmaier
Conférencier
University Hospital of Zurich (USZ), University of Zurich (UZH)L. Maul University Hospital of Zurich (USZ), University of Zurich (UZH)B. Becher University Hospital of Zurich (USZ), University of Zurich (UZH)T. Kündig University Hospital of Zurich (USZ), University of Zurich (UZH)C. Messner Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich (UZH)M. Levesque University Hospital of Zurich (USZ), University of Zurich (UZH)J. Maul University Hospital of Zurich (USZ), University of Zurich (UZH)
|
15876
|
Efficacy and Safety of Lebrikizumab is Maintained to Two Years in Patients with Moderate-to-Severe Atopic Dermatitis
Poster
1.1 Inflammatory and immune-mediated dermatoses
E. Guttman-Yassky Icahn School of Medicine at Mount Sinai, New York, NYS. Weidinger University Hospital Schleswig-Holstein, KielE. Simpson Oregon Health & Science University, PortlandM. Gooderham SKiN for Dermatology, Probity Medical Research and Queen’s University, Peterborough, OntarioA. Irvine Children’s Health Ireland, DublinL. Spelman Veracity Clinical Research, QueenslandJ. Silverberg George Washington University School of Medicine and Health Sciences, WashingtonL. DeLuca-Carter Eli Lilly and Company, IndianapolisL. Bardolet Almirall S.A., BarcelonaD. Thaçi
Conférencier
Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck
|
15877
|
Lebrikizumab Monotherapy Maintained Improvement of Itch and Sleep-Loss Due to Itch After Two Years in Patients with Moderate-to-Severe Atopic Dermatitis
Poster
1.1 Inflammatory and immune-mediated dermatoses
G. Yosipovitch Itch Center, Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami HospitalP. Lio Northwestern University Feinberg School of Medicine; Medical Dermatology Associates of Chicago, ChicagoD. Rosmarin Indiana University School of Medicine, IndianaM. Casillas Eli Lilly and Company, Indianapolis, IndianaE. Pierce Eli Lilly and Company, Indianapolis, IndianaL. Bardolet Almirall S.A., BarcelonaF. Legat Department of Dermatology, Medical University of Graz, GrazJ. Carrascosa Dermatology Department, Hospital Universitari Germans Trias i Pujol, UAB, IGTP, BadalonaS. Stander
Conférencier
Department of Dermatology and Center for Chronic Pruritus (KCP), University Hospital Münster, Münster
|
15879
|
Lymphatic filariasis
Poster
1.2 Infectious Diseases (including STD-STI)
M. Madanchi
Conférencier
Universitätsspital Basel (USB)P. Itin Private practice Dermatology
|
15880
|
X-Ray therapy of Skin Cancer at Critical Facial Sites: Results of a tertiary referral centre
Poster
2.1 Dermato-Oncology
S. Tschopp
Conférencier
Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, SwitzerlandA. Ciernik Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, SwitzerlandR. Dummer Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, SwitzerlandL. Imhof Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, Switzerland
|
15881
|
|
15882
|
Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with Chronic Hand Eczema (CHE): results of the Phase 3 open-label extension DELTA-3 trial
Poster
1.1 Inflammatory and immune-mediated dermatoses
M. Gooderham
Conférencier
Department of Medicine, Queens University, Kingston, Ontario, CanadaS. Molin Division of Dermatology, Queen's University, Kingston, CanadaR. Bissonnette Innovaderm Research, Montreal, Quebec, CanadaM. Worm Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité Universitätsmedizin Berlin, GermanyM. Crépy Department of Dermatology, University Hospital of Centre of Paris, Cochin Hospital, AP-HP, Paris, FranceL. Stingeni Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, ItalyR. Warren Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UKM. Oesterdal LEO Pharma A/S, Ballerup, DenmarkC. Balita-Crisostomo 12LEO Pharma A/SS. Schliemann Department of Dermatology, University Hospital Jena, Jena, GermanyT. Agner Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark
|
15883
|
|
15884
|
|
15887
|
Association between atopic dermatitis and cardiovascular diseases: Is it more complex?
Poster
3.2 Dermato-Allergology
D. Fehr
Conférencier
University Hospital Zurich, University of Zurich, Christine Kühne-Center for Allergy Research and Education (CK-CARE)L. Maintz University of Bonn, Christine Kühne-Center for Allergy Research and Education (CK-CARE)L. Tran Christine Kühne-Center for Allergy Research and Education (CK-CARE)C. Lang University Hospital Zurich, University of Zurich, Christine Kühne-Center for Allergy Research and Education (CK-CARE)C. Akdis Swiss Institute of Allergy and Asthma Research (SIAF), Christine Kühne-Center for Allergy Research and Education (CK-CARE)R. Lauener Children's Hospital of Eastern Switzerland, Christine Kühne-Center for Allergy Research and Education (CK-CARE)P. Schmid-Grendelmeier University Hospital Zurich, University of Zurich, Christine Kühne-Center for Allergy Research and Education (CK-CARE)C. Traidl-Hoffmann University of Augsburg, Christine Kühne-Center for Allergy Research and Education (CK-CARE)T. Bieber Christine Kühne-Center for Allergy Research and Education (CK-CARE)M. Brüggen University Hospital Zurich, University of Zurich, Christine Kühne-Center for Allergy Research and Education (CK-CARE)
|
15888
|
|
15889
|
A self-antigen-targeting LCMV-based vaccine platform for the treatment of solid tumors
Poster
2.1 Dermato-Oncology
M. Purde Kantonsspital St. GallenY. Palmowski University Hospital TübingenA. Makky University Hospital TübingenS. Schmidt HookipaPharmaH. Lauterbach HookipaPharmaK. Orlinger HookipaPharmaA. Cozzio
Conférencier
Kantonsspital St. GallenC. Schürch University Hospital TübingenS. Ring Kantonsspital St. GallenL. Flatz Kantonsspital St. Gallen
|
15890
|
Effective educational videos with the method of storytelling for reducing topical corticosteroid fear in parents of children with atopic dermatitis
Poster
3.1 Dermato-Paediatrics
C. Brunner
Conférencier
University Children's Hospital Zurich, Zurich, SwitzerlandA. Schlüer ZHAW Zurich University of Applied Sciences, Winterthur, SwitzerlandB. Seliner University Children's Hospital Zurich, Zurich, SwitzerlandH. Znoj University of Bern, Bern, SwitzerlandA. Schwieger-Briel University Children's Hospital Zurich, Zurich, SwitzerlandI. Luchsinger University Children's Hospital Zurich, Zurich, SwitzerlandL. Weibel University Children's Hospital Zurich, Zurich, SwitzerlandM. Theiler University Children's Hospital Zurich, Zurich, Switzerland
|
15891
|
|
15892
|
|
15893
|
Characteristics of a population with chronic pruritus in a Swiss university hospital: Pilot data from a new registry
Poster
3.7 Other topics – Not defined
L. Mildner
Conférencier
Department of Dermatology, University Hospital Basel, Basel, SwitzerlandE. Loos Department of Psychosomatic Medicine, University Hospital Basel, Basel, SwitzerlandA. Navarini Department of Dermatology, University Hospital Basel, Basel, SwitzerlandJ. Schneider Department of Dermatology, University Hospital Basel, Basel, SwitzerlandS. Ständer Department of Dermatology and Center for Chronic Pruritus (KCP), University Hospital Münster, Münster, GermanyS. Müller Department of Dermatology, University Hospital Basel, Basel, Switzerland
|
15894
|
|
15895
|
|
15897
|
Ipilimumab and nivolumab in uveal melanoma: report on toxicity and treatment intensity
Poster
2.1 Dermato-Oncology
A. Ciernik
Conférencier
Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, SwitzerlandL. Ciernik Machine Learning Group, Technische Universität Berlin, BIFOLD, 10587 Berlin, GermanyR. Dummer Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, SwitzerlandE. Ramelyte Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, Switzerland
|
15899
|
|
15900
|
Clinical Characteristics and Treatment Patterns of Psoriasis in Asia and Switzerland: results of the multicentre Global Healthcare Study on Psoriasis (GHSP)
Poster
1.1 Inflammatory and immune-mediated dermatoses
C. Ho
Conférencier
National Skin Centre, SingaporeL. Maul Department of Dermatology, University Hospital ZürichJ. Didaskalu Faculty of Medicine, University of ZurichM. Zheng Dermatology Department, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, ChinaL. Chularojanamontri Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandM. Ji Department of Dermatology, Skin Disease Prevention and Treatment of Fengxian District of Shanghai, ChinaB. Guevara Department of Dermatology, Southern Philippines Medical Centre, Davao City, PhilippinesJ. Maul Department of Dermatology, University Hospital ZürichH. Oon National Skin Centre and Skin Research Society of Singapore, Singapore
|
15901
|
Metastatic Melanoma in Multiple Sclerosis Patients Following Long-Term Fingolimod Treatment: A Report of Two Cases
Poster
2.1 Dermato-Oncology
A. Ciernik
Conférencier
E. Ramelyte Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, SwitzerlandJ. Mangana Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, SwitzerlandR. Dummer Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, Switzerland
|
15909
|
|
15910
|
Bimekizumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Pooled analysis from up to 3 years of treatment in 5 phase 3/3b clinical trials
Poster
1.1 Inflammatory and immune-mediated dermatoses
B. Strober Department of Dermatology, Yale University, New Haven and Central Connecticut Dermatology ResearchJ. Krueger Centre for Clinical and Translational Science, The Rockerfeller UniversityN. Magnolo University Hospital MünsterR. Vender Dermatrials Research Inc.W. Boehncke Division of Dermatology and Venereology, Department of Medicine, Geneva University Hospitals and Department of Pathology and Immunology, Faculty of Medicine, University of GenevaC. Hong University of British ColumbiaN. Tilt UCB PharmaF. Staelens UCB PharmaB. Hoepken UCB PharmaS. Wiegratz UCB PharmaN. Hurni
Conférencier
UCB PharmaC. Paul Toulouse University and CHU
|
15911
|
Bimekizumab response through 3 years in patients with plaque psoriasis who stopped and re-started treatment
Poster
1.1 Inflammatory and immune-mediated dermatoses
A. Costanzo Humanitas Clinical and Research Centre, IRCCSK. Papp Probity Medical Research and Alliance Clinical Trials, Waterloo and University of Toronto, TorontoC. Griffiths University of Manchester, Manchester and King’s College LondonD. Rosmarin Indiana University School of MedicineL. Puig Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de BarcelonaG. Han Mount Sinai Medical CenterN. Tilt UCB PharmaK. Wixted UCB PharmaB. Szilagyi UCB PharmaJ. Lambert UCB PharmaN. Hurni
Conférencier
UCB PharmaA. Blauvelt Oregon Medical Research Center
|
15912
|
Dupilumab Reduces Itch in Atopic Dermatitis and Prurigo Nodularis
Poster
1.1 Inflammatory and immune-mediated dermatoses
G. Yosipovitch University of Miami, Miller School of Medicine, Miami, FL, USAS. Straub
Conférencier
Sanofi-aventis (Swiss) SA, Switzerland. *Sebastian Straub has been added to serve as a presenter. Sanofi medical employees (Sebastian Straub and Michael Perny) will attend the congress and can address HCPs/researchers questions.B. Kim Icahn School of Medicine at Mount Sinai, Department of Dermatology, New York, NY, USAJ. Koo University of California San Francisco Psoriasis and Skin Treatment Center, San Francisco, CA, USAZ. Chen Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAS. Wiggins Sanofi, Reading, UKJ. Zahn Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAE. Haddad Sanofi, Cambridge, MA, USA S. Cyr Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA
|
15913
|
|
15915
|
Genetic testing of a child with idiopathic chronic pruritus
Poster
3.1 Dermato-Paediatrics
A. Schwieger-Briel
Conférencier
Zentrum Kinderhaut, Universitätsspital ZürichB. Meier-Schiesser UniSpital ZürichJ. Kamarachev UniSpital ZürichI. Luchsinger Zentrum Kinderhaut, Universitätsspital ZürichJ. Lanz Zentrum Kinderhaut, Universitätsspital ZürichL. Weibel Zentrum Kinderhaut, Universitätsspital ZürichM. Theiler Zentrum Kinderhaut, Universitätsspital Zürich
|
15916
|
An investigation of metal- and additive-allergy patterns in 225 prosthesis patients
Poster
3.2 Dermato-Allergology
T. El Saadany
Conférencier
UniversitätsSpital ZürichB. Illi Stadtspital Triemli ZürichP. Furrer Balgrist HospitalP. Schenk Hospital of UsterS. Fucentese Balgrist HospitalN. Li UniversitätsSpital ZürichP. Schmid-Grendelmeier UniversitätsSpital ZürichC. Lang UniversitätsSpital ZürichK. Bärenfaller Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich (UZH)D. Zhakparov Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich (UZH)M. Brüggen UniversitätsSpital Zürich
|
15917
|
A deep-learning model to facilitate cancer diagnosis in recessive dystrophic epidermolysis bullosa
Poster
3.5 Genodermatoses
A. Reimer-Taschenbrecker
Conférencier
Inselspital - Universitätsspital BernA. Furmanchuk Northwestern University Feinberg School of Medicine A. Adate Northwestern UniversityW. Temps Northwestern University Feinberg School of Medicine M. Meredith Northwestern University Feinberg School of Medicine A. Hwang Northwestern University Feinberg School of Medicine D. Bhuva Northwestern University Feinberg School of Medicine B. Nardone Northwestern University Feinberg School of Medicine A. Katsaggelos Northwestern UniversityA. Kho Northwestern University Feinberg School of Medicine A. Paller Northwestern University Feinberg School of Medicine
|
15918
|
|
15919
|
|
15923
|
Bilateral Nicolau syndrome following intramuscular gentamicin Injections
Poster
3.6 Surgery
K. Kotsia
Conférencier
Inselspital, Bern University Hospital, University of BernL. Gueissaz Inselspital, Bern University Hospital, University of BernM. Lehmann Inselspital, Bern University Hospital, University of BernR. Blum Inselspital, Bern University Hospital, University of BernL. Borradori Inselspital, Bern University Hospital, University of Bern
|
15925
|
|
15928
|
The Patient Burden of Indolent Systemic Mastocytosis in Europe: Results From the PRISM Patient Survey
Poster
3.2 Dermato-Allergology
K. Hartmann
Conférencier
University Hospital Basel; University of BaselF. Ruëff University Hospital Ludwig-Maximillian University of MunichD. Radia Guy's and St Thomas' NHS Foundation TrustM. Triggiani University of SalernoI. Alvarez-Twose Institute of Mastocytosis Studies of Castilla-La Mancha (CLMast)C. Livideanu French Reference Center for Mastocytosis (CEREMAST), Toulouse University HospitalN. Hegmann Mastocytosis Self-Support Network, eVW. Schinhofen The Mastocytosis Self-Help Network eVJ. Hobart The UK Mastocytosis Support GroupR. Mesa Atrium Health Wake Forest Baptist Comprehensive Cancer Center
|
15929
|
MHC-I Upregulation Safeguards Neoplastic T Cells in the Skin Against NK Cell-mediated Eradication in Mycosis Fungoides
Poster
3.4 Basic and Translational Research
Y. Chang
Conférencier
Lausanne University Hospital (CHUV)P. Prompsy Lausanne University Hospital (CHUV)S. Kimeswenger Johannes Kepler UniversityY. Tsai Lausanne University Hospital (CHUV)C. Iselin Lausanne University Hospital (CHUV)L. French Ludwig-Maximilians-University of MunichM. Levesque University hospital of ZurichF. Kuonen Lausanne University Hospital (CHUV)P. Brunner Icahn School of Medicine at Mount SinaiS. Pascolo University hospital of ZurichW. Hoetzenecker Johannes Kepler UniversityE. Guenova Lausanne University Hospital (CHUV)
|
15930
|
|
15931
|
|
15933
|
|
15934
|
|
15936
|
Multi-omics cytokine screening reveals immunosuppressive microenvironment in cutaneous T-cell lymphoma.
Poster
3.4 Basic and Translational Research
Y. Tsai
Conférencier
Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)Y. Chang Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)P. Prompsy Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)C. Iselin Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)E. Guenova Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
|
15937
|
|
15938
|
Dosimetry of Realistic 3D Human Skin Models at the Millimeter Waves Band of 5G
Poster
3.4 Basic and Translational Research
S. Iakovidis Aristotle University of ThessalonikiC. Pich-Bavastro Centre Hospitalier Universitaire de Lausanne and University of Lausanne, Lausanne, SwitzerlandZ. Su Centre Hospitalier Universitaire de Lausanne and University of Lausanne, Lausanne, SwitzerlandD. Kapoukranidou Aristotle University of ThessalonikiO. Gaide
Conférencier
Centre Hospitalier Universitaire de Lausanne and University of Lausanne, Lausanne, SwitzerlandT. Samaras Aristotle University of Thessaloniki
|
15939
|
|
15940
|
|
15941
|
|
15944
|
|
15945
|
|
15946
|
Efficacy of Dupilumab Treatment in Atopic Hand And Foot Dermatitis Across Morphological Subtypes: Results From a Phase 3, Randomized, Double-blind, Placebo-controlled Trial
Poster
1.1 Inflammatory and immune-mediated dermatoses
M. Worm Charité-Universitätsmedizin Berlin, Berlin, GermanyS. Straub
Conférencier
Sanofi-aventis (Swiss) SA, Switzerland. *Sebastian Straub has been added to serve as a presenter. Sanofi medical employees (Sebastian Straub and Michael Perny) will attend the congress and can address HCPs/researchers questions.E. Simpson Oregon Health & Science University, Portland, OR, USAW. Soong Allervie Health/Alabama Allergy & Asthma Center, Birmingham, AL, USAA. Pinter University Hospital Frankfurt am Main, Frankfurt am Main, GermanyL. Shao Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAA. Dubost-Brama Sanofi, Chilly-Mazarin, FranceA. Bansal Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAA. Korotzer Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAA. Rossi Sanofi, Cambridge, MA, USA
|
15948
|
Contact dermatitis of a different kind: the beach vacationer's travel souvenir
Poster
1.1 Inflammatory and immune-mediated dermatoses
S. Cerminara
Conférencier
Universitätsspital BaselJ. Jost
Conférencier
Universitätsspital BaselR. Curatolo Universitätsspital BaselA. Müller Universitätsspital BaselH. Juratli Universitätsspital BaselA. Navarini Universitätsspital BaselM. Madanchi Universitätsspital Basel
|
15949
|
Differences in survival of melanoma patients after immune checkpoint inhibitor discontinuation for response or toxicity - a single center analysis by patient sex
Poster
2.1 Dermato-Oncology
C. Zahn
Conférencier
Department of Dermatology, Inselspital, Bern University HospitalF. Cerciello Department of Medical Oncology, Inselspital, Bern University HospitalC. Ryser Department of Medical Oncology, Inselspital, Bern University HospitalR. Bill Department of Medical Oncology, Inselspital, Bern University HospitalK. Gysel Swiss Group for Clinical Cancer Research (SAKK) Competence CenterB. Özdemir Department of Medical Oncology, Inselspital, Bern University Hospital
|
15950
|
|
15951
|
The dark side of itch
Poster
2.1 Dermato-Oncology
A. Pagani
Conférencier
EOCG. Caro EOCC. Mangas EOCH. Beltraminelli EOC
|
15952
|
|
15953
|
|
15954
|
|
15955
|
|
15956
|
Solitary Cutaneous Schwannoma Mimicking a Basal Cell Carcinoma
Poster
2.1 Dermato-Oncology
C. Mainetti
Conférencier
Studio Medico DermatologiaK. Gadaldi Department of Dermatology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland, Department of Pathology, Ente Ospedaliero Cantonale, Locarno, SwitzerlandH. Beltraminelli Department of Dermatology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland, Department of Pathology, Ente Ospedaliero Cantonale, Locarno, Switzerland
|
15958
|
Chronic and ulcerated necrobiosis lipoidica of the elbow: a new entity
Poster
1.1 Inflammatory and immune-mediated dermatoses
A. Rabufetti
Conférencier
Inselspital University Hospital Bern, University of Bern, Bern, SwitzerlandB. Signer
Conférencier
Inselspital University Hospital Bern, University of Bern, Bern, SwitzerlandL. Farnina Inselspital University Hospital Bern, University of Bern, Bern, SwitzerlandM. Lehmann Inselspital University Hospital Bern, University of Bern, Bern, SwitzerlandL. Feldmeyer Inselspital University Hospital Bern, University of Bern, Bern, SwitzerlandD. Lipsker Hôpitaux Universitaires et Université de StrasbourgL. Borradori Inselspital University Hospital Bern, University of Bern, Bern, Switzerland
|
15959
|
|
15960
|
|
15961
|
|
15962
|
|
15964
|
Pruritus and Quality of Life in Patients with Cutaneous T-cell Lymphoma
Poster
2.1 Dermato-Oncology
A. Roggo
Conférencier
Department of Dermatology, University Hospital Zürich, University of Zürich, SwitzerlandY. Wüest Department of Dermatology, University Hospital Zürich, University of Zürich, SwitzerlandR. Dummer Department of Dermatology, University Hospital Zürich, University of Zürich, SwitzerlandE. Ramelyte Department of Dermatology, University Hospital Zürich, University of Zürich, Switzerland
|
15967
|
|
15968
|
|
15969
|
|
15971
|
|
15972
|
|
15973
|
|
15974
|
|
15975
|
|
15976
|
A retrospective analysis of Spitz Tumors using MelArray next-generation-sequencing
Poster
2.1 Dermato-Oncology
M. Teufer
Conférencier
Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, SwitzerlandE. Ramelyte Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, SwitzerlandR. Dummer Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8091 Zurich, Switzerland
|
15980
|
Metabolic Shifts in Hidradenitis Suppurativa Lesions: Insights from Transcriptomic Analyses and Implications for Therapeutic Strategies
Poster
3.4 Basic and Translational Research
A. Hosseini
Conférencier
Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Schärli Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandF. Luther Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandD. Simon Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandL. Borradori Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. von Gunten Institute of Pharmacology, University of Bern, Bern, SwitzerlandN. Yawalkar Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandL. Feldmeyer Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandR. Hunger Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandC. Schlapbach Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandM. Jafari Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
|
15981
|
|
15983
|
Zinc: a painful deficiency
Poster
1.1 Inflammatory and immune-mediated dermatoses
A. Pagani
Conférencier
EOCG. Caro EOCC. Mangas EOCH. Beltraminelli EOC
|
15984
|
|
15985
|
Case report - Tularemia
Poster
1.2 Infectious Diseases (including STD-STI)
E. Burri
Conférencier
A. Schwieger-Briel Kinderspital Zürich - Eleonorenstiftung
|
15987
|
|
15988
|
|
15989
|
|
15990
|
|
15991
|
|
15992
|
|
15993
|
|
15994
|
Barbershop Tinea – when the undercut leaves you with an extra souvenir
Poster
1.2 Infectious Diseases (including STD-STI)
C. Pelzer
Conférencier
Clinic for Dermatology, Venerology and Allergology, Kantonsspital St. Gallen, St. Gallen, SwitzerlandS. Uhrlass Labopart – Medizinische Laboratorien, Rötha OT Mölbis, GermanyP. Nenoff Labopart – Medizinische Laboratorien, Rötha OT Mölbis, GermanyK. Belge Group Practice Reinacherhof, Reinach (BL), SwitzerlandP. Bosshard Department of Dermatology, University Hospital Zürich, Zürich, SwitzerlandL. Fontao Division of Dermatology, Geneva University Hospitals, Geneva, Switzerland; Division of laboratory medicine, Geneva University Hospitals, Geneva, SwitzerlandC. Lang Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, SwitzerlandA. Cozzio Clinic for Dermatology, Venerology and Allergology, Kantonsspital St. Gallen, St. Gallen, Switzerland
|
15996
|
Effect of betablockers on the course of Martorell hypertensive ulcers: a retrospective study
Poster
3.3 Dermato-Pathology
O. Pavlova
Conférencier
Lausanne University Hospital (CHUV) and the University of Lausanne (UNIL)L. Cleusix Lausanne University Hospital (CHUV) and the University of Lausanne (UNIL)E. Guenova Lausanne University Hospital (CHUV) and the University of Lausanne (UNIL)F. Kuonen Lausanne University Hospital (CHUV) and the University of Lausanne (UNIL)
|
15997
|
Multi-Harmonic Imaging-Based Automated Recognition of Cutaneous T-Cell Lymphoma
Poster
2.3 Therapy, diagnostic tools, and devices
O. Pavlova
Conférencier
Lausanne University Hospital (CHUV) and the University of Lausanne (UNIL)S. Ghosh Geneva UniversityD. Kim Geneva UniversityY. Chang Lausanne University Hospital (CHUV) and the University of Lausanne (UNIL)Y. Tsai Lausanne University Hospital (CHUV) and the University of Lausanne (UNIL)C. Iselin Lausanne University Hospital (CHUV) and the University of Lausanne (UNIL)P. Prompsy Lausanne University Hospital (CHUV) and the University of Lausanne (UNIL)D. Staedler Lausanne UniversityL. Bonacina Geneva UniversityE. Guenova Lausanne University Hospital (CHUV) and the University of Lausanne (UNIL)
|
15998
|
|
16000
|
IL17 inhibitor as a new treatment for congenital ichtyosis
Poster
3.5 Genodermatoses
F. Minisini
Conférencier
CHUV - University Hospital LausanneA. Nidegger CHUV - University Hospital LausanneC. Conrad CHUV - University Hospital LausanneJ. Di Domizio CHUV - University Hospital LausanneT. Caplanusi CHUV - University Hospital LausanneM. Gilliet CHUV - University Hospital LausanneM. Morren CHUV - University Hospital Lausanne
|
16001
|
|
16063
|
Case report: Levothyroxine-induced Bullous Pemphigoid ?
Poster
1.1 Inflammatory and immune-mediated dermatoses
R. Iuliano
Conférencier
CHUV & Université de LausanneH. Wuthrich CHUV & Université de LausanneM. Gilliet CHUV & Université de LausanneT. Caplanusi CHUV & Université de Lausanne
|
16064
|
|
16065
|
|
16067
|
|
16068
|
|
16069
|
Novel KIT Mutation, D816_N819delinsII, in a Patient with Systemic Mastocytosis: A Case Report
Poster
3.2 Dermato-Allergology
H. Wassmer
Conférencier
University Hospital Basel / University of BaselD. Juskevicius University Hospital Basel / University of BaselI. Alborelli University Hospital Basel / University of BaselA. Tzankov University Hospital Basel / University of BaselC. Widmer University Hospital Basel / University of BaselK. Hartmann University Hospital Basel / University of Basel
|
16070
|
|
16111
|
|